JP2002520286A5 - - Google Patents

Download PDF

Info

Publication number
JP2002520286A5
JP2002520286A5 JP2000558822A JP2000558822A JP2002520286A5 JP 2002520286 A5 JP2002520286 A5 JP 2002520286A5 JP 2000558822 A JP2000558822 A JP 2000558822A JP 2000558822 A JP2000558822 A JP 2000558822A JP 2002520286 A5 JP2002520286 A5 JP 2002520286A5
Authority
JP
Japan
Prior art keywords
composition
formula
caffeine
compound
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000558822A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002520286A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/013670 external-priority patent/WO2000002562A1/en
Publication of JP2002520286A publication Critical patent/JP2002520286A/ja
Publication of JP2002520286A5 publication Critical patent/JP2002520286A5/ja
Withdrawn legal-status Critical Current

Links

JP2000558822A 1998-07-09 1999-06-18 Gaba類縁体及びカフェインを含んでなる組成物 Withdrawn JP2002520286A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9213198P 1998-07-09 1998-07-09
US60/092,131 1998-07-09
PCT/US1999/013670 WO2000002562A1 (en) 1998-07-09 1999-06-18 Compositions comprising gaba analogs and caffeine

Publications (2)

Publication Number Publication Date
JP2002520286A JP2002520286A (ja) 2002-07-09
JP2002520286A5 true JP2002520286A5 (https=) 2006-08-10

Family

ID=22231777

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000558822A Withdrawn JP2002520286A (ja) 1998-07-09 1999-06-18 Gaba類縁体及びカフェインを含んでなる組成物

Country Status (13)

Country Link
US (1) US6326374B1 (https=)
EP (1) EP1094817A1 (https=)
JP (1) JP2002520286A (https=)
KR (1) KR20010071777A (https=)
AU (1) AU772156B2 (https=)
BR (1) BR9911917A (https=)
CA (1) CA2332915C (https=)
ID (1) ID28277A (https=)
NO (1) NO20010119L (https=)
NZ (1) NZ508490A (https=)
PL (1) PL345340A1 (https=)
WO (1) WO2000002562A1 (https=)
ZA (1) ZA200007168B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL189872B1 (pl) 1996-07-24 2005-10-31 Warner Lambert Co Zastosowanie izobutylogaby i jej pochodnych do wytwarzania leku do leczenia bólu
US6992109B1 (en) * 1999-04-08 2006-01-31 Segal Catherine A Method for the treatment of incontinence
DK1169060T3 (da) * 1999-04-09 2006-01-16 Euro Celtique Sa Natriumkanalblokkerpræparater og anvendelse deraf
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
DK1423168T3 (da) * 2001-09-03 2006-05-15 Newron Pharm Spa Farmaceutisk præparat omfattende gabapentin eller en analog deraf og et alfa-aminoamid og dets analgetiske anvendelse
ES2292107T3 (es) * 2004-03-12 2008-03-01 Warner-Lambert Company Llc Ligandos de bifosfina simetricos en c1 y su uso en la sintesis asimetrica de pregabalina.
EP1735324B1 (en) * 2004-04-01 2008-08-20 Warner-Lambert Company LLC Preparation of p-chirogenic phospholanes and their use in asymetric synthesis
HRP20100054T1 (hr) * 2004-06-21 2010-05-31 Warner-Lambert Company Llc Dobivanje pregabalina i njemu sličnih spojeva
DK1809271T5 (da) * 2004-09-10 2010-12-06 Newron Pharm Spa Anvendelse af (R)-(halogenbenzyloxy)benzylaminopropanamider som natrium- og/eller calciumkanalselektive modulatorer
EP1963280B1 (en) 2005-12-22 2015-10-28 Newron Pharmaceuticals S.p.A. 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
US7645767B2 (en) * 2006-08-31 2010-01-12 Trinity Laboratories, Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
CH699327B1 (de) 2007-02-14 2010-03-15 Oerlikon Heberlein Temco Wattw Vorrichtung zum gleichzeitigen Behandeln von mehreren multifilen Fäden.
WO2009021058A2 (en) 2007-08-06 2009-02-12 Trinity Labortories, Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
SG157299A1 (en) 2008-05-09 2009-12-29 Agency Science Tech & Res Diagnosis and treatment of kawasaki disease
US20100190752A1 (en) * 2008-09-05 2010-07-29 Gruenenthal Gmbh Pharmaceutical Combination
WO2011141923A2 (en) 2010-05-14 2011-11-17 Lupin Limited Improved synthesis of optically pure (s) - 3-cyano-5-methyl-hexanoic acid alkyl ester, an intermediate of (s)- pregabalin
WO2012059797A1 (en) 2010-11-04 2012-05-10 Lupin Limited Process for synthesis of (s) - pregabalin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656177A (en) * 1982-07-22 1987-04-07 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US5248678A (en) * 1992-06-30 1993-09-28 Fractal Laboratories, Inc. Methods for increasing arousal and alertness and for the amelioration of comatose states
BR9407415A (pt) * 1993-09-07 1996-11-12 Procter & Gamble Composições contendo um sal de aminoácido de agente antiinflamatório não-esteróide de ácido propiônico e caféina
US5443838A (en) * 1993-09-15 1995-08-22 Koenig, Jr.; Steven M. Nutritional supplementation system
UA49011C2 (uk) * 1996-03-14 2002-09-16 Варнер-Ламберт Компані Похідні циклічної амінокислоти, фармацевтична композиція та спосіб лікування
WO1998007447A1 (en) 1996-08-23 1998-02-26 Algos Pharmaceutical Corporation Anticonvulsant containing composition for treating neuropathic pain
WO1998017627A1 (en) * 1996-10-23 1998-04-30 Warner-Lambert Company Substituted gamma aminobutyric acids as pharmaceutical agents
JP3782935B2 (ja) * 1997-09-08 2006-06-07 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 抗癲癇化合物を含有する鎮痛剤組成物およびその使用方法

Similar Documents

Publication Publication Date Title
JP2002520286A5 (https=)
JP2001515033A5 (https=)
JP2003528918A5 (https=)
JP2002527474A5 (ja) 躁病および双極性障害の治療のための医薬
JP2002508352A5 (ja) 4(3)置換−4(3)−アミノメチル−(チオ)ピラン又はピペリジン誘導体(=ガバペンチン類似体)
JP2001515859A5 (https=)
JP2002502874A5 (https=)
JP2002519425A5 (https=)
JP2002519434A5 (https=)
JP2002508362A5 (ja) 1−置換−1−アミノメチル−シクロアルカン誘導体(=ガバペンチン類縁体)
JP2003531118A5 (https=)
JP2002533472A5 (https=)
JP2002518502A5 (https=)
JP2001512743A5 (https=)
JP2002541233A5 (https=)
JP2002509153A5 (https=)
JP2002541198A5 (ja) 失禁治療用医薬組成物
JP2001526218A5 (https=)
CA2526534A1 (en) Compounds and methods for delivery of prostacyclin analogs
JP2003514783A5 (https=)
JP2004530641A5 (https=)
JP2002531505A5 (https=)
JP2002536359A5 (https=)
JP2002508361A5 (https=)
JP2002527396A5 (https=)